vimarsana.com
Home
Live Updates
Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update : comparemela.com
Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update
- Q2 total revenue of $58.1 million, a YoY increase of 104.9%.
- Q2 RHA® Collection revenue of $31.8 million, a YoY increase of 24.7%.
- Q2 DAXXIFY® revenue of $22.6 million, a QoQ increase of...
Related Keywords
California ,
United States ,
Irvine ,
China ,
Tennessee ,
Fosun Pharma ,
Markj Foley ,
Securities Exchange ,
China National Medical Products Administration ,
Viatris Inc ,
Drug Administration ,
Revance Therapeutics Inc ,
Hint Inc ,
Exchange Commission ,
Linkedin ,
Revance Therapeutics ,
Athyrium Capital ,
Note Purchase Agreement ,
Second Tranche ,
Third Tranche ,
Chief Executive Officer ,
Investor Day ,
Quarter Highlights ,
Relational Commerce ,
National Medical Products Administration ,
Hyaluronic Acid ,
Private Securities Litigation Reform Act ,
Securities Act ,
Securities Exchange Act ,
Consolidated Statements ,
Months Ended June ,
Revenue Breakdown ,
Markets ,
comparemela.com © 2020. All Rights Reserved.